[Clinical evaluation of eribulin mesylate for the treatment of metastatic breast cancer].

Matsuzaki, Hiroshi; Tohnosu, Noriyuki; Yoshiwara, Chisato; Maruyama, Takashi; Tanaka, Hajime; Natsume, Toshiyuki; Miyazaki, Akinari; Sato, Yayoi; Ohta, Takumi; Yamamoto, Yuji; Aikawa, Mizuho; Ohtsuka, Ryota; Yanagihara, Akitoshi; Iwata, Kanae; Shiratori, Toru; Miyazawa, Yukimasa

Matsuzaki, Hiroshi; Tohnosu, Noriyuki; Yoshiwara, Chisato; Maruyama, Takashi; Tanaka, Hajime; Natsume, Toshiyuki; Miyazaki, Akinari; Sato, Yayoi; Ohta, Takumi; Yamamoto, Yuji; Aikawa, Mizuho; Ohtsuka, Ryota; Yanagihara, Akitoshi; Iwata, Kanae; Shiratori, Toru; Miyazawa, Yukimasa.

Affiliation

Matsuzaki H; Dept. of Surgery,Funabashi Municipal Medical Center.

Gan To Kagaku Ryoho ; 41(4): 455-9, 2014 Apr.

Article in Ja | MEDLINE | ID: mdl-24743360

Subject(s)

Breast Neoplasms/drug therapy; Furans/therapeutic use; Ketones/therapeutic use; Aged; Aged, 80 and over; Breast Neoplasms/pathology; Disease Progression; Furans/adverse effects; Humans; Ketones/adverse effects; Middle Aged; Prognosis; Tomography, X-Ray Computed

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Furans / Ketones Type of study: Prognostic_studies Limits: Aged / Aged80 / Humans / Middle aged Language: Ja Journal: Gan To Kagaku Ryoho Year: 2014 Type: Article

Search on Google

XML

PubMed Links